Partner Headlines - GSK

  1. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) ...

    Benzinga
  2. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  3. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus
  4. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta ...

    Benzinga
  5. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  6. Intermune up on buyout buzz

    IBD
  7. You Should Consider Adding GlaxoSmithKline Based on Tremendous ...

    GuruFocus
  8. Drugmaker AstraZeneca Returns To Growth

    IBD
  9. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  10. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives ...

    Benzinga
  11. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  12. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  13. Glaxo, Genmab Report Positive Interim Result for Phase III Study ...

    Benzinga
  14. A Look at the Week's Top Dividend Growers

    GuruFocus
  15. Markets Little Changed Ahead Of The Federal Reserve's Policy ...

    Benzinga
  16. GlaxoSmithKline

    IBD
  17. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  18. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine ...

    Benzinga
  19. Morning Market Movers

    Benzinga
  20. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  21. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  22. British Stocks: Sweet Spot For European Value

    YCharts
  23. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  24. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart ...

    Benzinga
  25. Advances In HIV, Hep C Treatments Could Spark Renewed Interest ...

    Benzinga
  26. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  27. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies ...

    Benzinga
  28. Major British Companies Lead Top Guru-Held UK and Ireland Stocks ...

    GuruFocus
  29. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  30. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  31. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  32. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  33. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  34. Can Pfizer Make Up Its Loss?

    GuruFocus
  35. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  36. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  37. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  38. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing ...

    Benzinga
  39. Glaxo hurt by Advair scandal

    IBD
  40. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  41. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  42. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  43. China Rule Change Further Opens Yuan To World Markets

    IBD
  44. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus
  45. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine ...

    Benzinga
  46. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  47. Benzinga Weekly Preview: Earnings Season Continues As Biotech ...

    Benzinga
  48. Big Pharmas Swap Specialties

    IBD
  49. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  50. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  51. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  52. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  53. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  54. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  55. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  56. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  57. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  58. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  59. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  60. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  61. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  62. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  63. GlaxoSmithKline Finally Received Approval from FDA for Its Diabetes ...

    GuruFocus
  64. Has A Streamlined FDA Raised The Value Of Drug Stocks?

    IBD
  65. Pharmaceutical Stocks For Income, Value, And Growth Investors

    Benzinga
  66. New Glaxo bribery inquiries

    IBD
  67. Race for Vaccines, Treatments as West Africa Ebola Death Toll ...

    Benzinga
  68. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  69. GlaxoSmithKline

    IBD
  70. Amgen, GSK End Marketing Pact for Osteoporosis Drug

    FoxBusiness
  71. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  72. Glaxosmithkline Confirms Warning Letter Received from FDA o March ...

    Benzinga
  73. GSK buys up Indonesia unit

    IBD
  74. GSK Recalls Alli in U.S. After Package Tampering

    FoxBusiness
  75. GSK, FDA Probe Tampering of Weight-Loss Drug Alli

    FoxBusiness
  76. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  77. Market Wrap For March 20: Investors Showing No Post-Fed Decision ...

    Benzinga
  78. Glaxo Cancer Vaccine Fails, Testing Continues

    FoxBusiness
  79. Morning Market Losers

    Benzinga
  80. US Stock Futures Drop Ahead Of Jobless Claims Report

    Benzinga
  81. Agenus Therapeutics Reports GlaxoSmithKline's Magrit Study Does ...

    Benzinga
  82. T. Rowe Price's Brian Rogers Joins GuruFocus for Q&A - Ask an ...

    GuruFocus
  83. T. Rowe Price CIO Brian Rogers Joins GuruFocus for Q&A - Ask ...

    GuruFocus
  84. Gilead's HCV Challengers Near The Starting Gate

    IBD
  85. Brian Rogers of T. Rowe Price Joins GuruFocus for Q&A - Ask a ...

    GuruFocus
  86. Gilead's HCV Challengers Near The Starting Gate

    IBD
  87. Prosensa Muscular Dystrophy Data Send Stock Rising

    IBD
  88. A HIV shot could replace pills

    IBD
  89. Why Long-Term Investor Warren Buffett's Company Just Sold 2 Stocks

    GuruFocus
  90. GlaxoSmithKline, Kinder Morgan And Others Insiders Have Been ...

    Benzinga
  91. Glaxo's COPD Drug Gets European Green Light

    FoxBusiness
  92. Berkshire Hathaway Files SEC 13F

    Benzinga
  93. Pharmacyclics' Imbruvica Wins Second Cancer Approval

    IBD
  94. Novartis' 'Cliffy' Business

    GuruFocus
  95. Glaxo expects to retain lead

    IBD
  96. Benzinga Weekly Preview: Twitter To Release Earnings For The ...

    Benzinga
  97. Ariad Shares Continue to Surge Amidst Buyout Rumors

    Benzinga
  98. Tweedy Browne Global Value Fund New Buy and Adds

    GuruFocus
  99. Pharmacyclics: Facts Behind $10B Market Cap

    YCharts
  100. $10B Market By 2022: Pharmacyclic’s Piece Of It

    YCharts
Trading Center